Top

Published in:

01-12-2020 | Echinococcosis | Brief Report

Spatial distribution and incidence trend of human alveolar echinococcosis in southwest Germany: increased incidence and urbanization of the disease?

Authors: Matthias C. Mueller, Michael Marx, Gabriele Peyerl-Hoffmann, Winfried V. Kern

Published in: Infection | Issue 6/2020

Abstract

Ecology and epidemiology of Echinococcus multilocularis and human alveolar echinococcosis (AE) are changing in Central Europe. Our data from a regional referral center for AE in southwest Germany suggest rising regional incidence for AE (annual incidence per 100,000 population 2004–2011: 0.12; 2012–2019: 0.20) and emerging urban AE (of 7 cases of AE in Freiburg city dwellers none was diagnosed before 2012) calling for an intensification of E. multilocularis and AE surveillance and of AE prevention measures.

Available only for authorised users

König A, Romig T, Thoma D, Kellermann K. Drastic increase in the prevalence of Echinococcus multilocularis in foxes (Vulpes vulpes) in southern Bavaria, Germany. Eur J Wildl Res. 2005;51:277–82. https://doi.org/10.1007/s10344-005-0100-5.CrossRef

Romig T, Bilger B, Dinkel A, Merli M, Mackenstedt U. Echinococcus multilocularis in animal hosts: new data from western Europe. Helminthologia. 1999;36:185–91.

Deplazes P, Hegglin D, Gloor S, Romig T. Wilderness in the city: the urbanization of Echinococcus multilocularis. Trends Parasitol. 2004;20:77–84. https://doi.org/10.1016/j.pt.2003.11.011.CrossRefPubMed

Hofer S, Gloor S, Müller U, Mathis A, Hegglin D, Deplazes P. High prevalence of Echinococcus multilocularis in urban red foxes (Vulpes vulpes) and voles (Arvicola terrestris) in the city of Zürich, Switzerland. Parasitology. 2000;120:135–42. https://doi.org/10.1017/s0031182099005351.CrossRefPubMed

Vuitton DA, Demonmerot F, Knapp J, Richou C, Grenouillet F, Chauchet A, Vuitton L, Bresson-Hadni S, Millon L. Clinical epidemiology of human AE in Europe. Vet Parasitol. 2015;213:110–20. https://doi.org/10.1016/j.vetpar.2015.07.036.CrossRefPubMed

Schweiger A, Ammann RW, Candinas D, Clavien P-A, Eckert J, Gottstein B, Halkic N, Muellhaupt B, Prinz BM, Reichen J, Tarr PE, Torgerson PR, Deplazes P. Human alveolar echinococcosis after fox population increase, Switzerland. Emerg Infect Dis. 2007;13:878–82. https://doi.org/10.3201/eid1306.061074.CrossRefPubMedPubMedCentral

Schmidberger J, Kratzer W, Stark K, Grüner B, Echinococcosis Working Group. Alveolar echinococcosis in Germany, 1992–2016. An update based on the newly established national AE database. Infection. 2018;46:197–206. https://doi.org/10.1007/s15010-017-1094-0.CrossRefPubMed

Robert Koch Institut Robert Koch-Institut: SurvStat@RKI 2.0. https://survstat.rki.de. Abfragedatum 04 Feb 2020.

Gottstein B, Stojkovic M, Vuitton DA, Millon L, Marcinkute A, Deplazes P. Threat of alveolar echinococcosis to public health—a challenge for Europe. Trends Parasitol. 2015;31:407–12. https://doi.org/10.1016/j.pt.2015.06.001.CrossRefPubMed

10.

Jorgensen P, an der Heiden M, Kern P, Schöneberg I, Krause G, Alpers K. Underreporting of human alveolar echinococcosis, Germany. Emerg Infect Dis. 2008;14:935–7. https://doi.org/10.3201/eid1406.071173.CrossRefPubMedPubMedCentral

11.

Brunetti E, Kern P, Vuitton DA. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114:1–16. https://doi.org/10.1016/j.actatropica.2009.11.001.CrossRefPubMed

12.

Schneider R, Aspöck H, Auer H. Unexpected increase of alveolar echincoccosis, Austria, 2011. Emerg Infect Dis. 2013;19:475–7. https://doi.org/10.3201/eid1903.120595.CrossRefPubMedPubMedCentral

13.

Nothdurft HD, Jelinek T, Mai A, Sigl B, von Sonnenburg F, Löscher T. Epidemiology of alveolar echinococcosis in southern Germany (Bavaria). Infection. 1995;23:85–8. https://doi.org/10.1007/BF01833871.CrossRefPubMed

14.

Jenkins DJ, Romig T, Thompson RCA. Emergence/re-emergence of Echinococcus spp.—a global update. Int J Parasitol. 2005;35:1205–19. https://doi.org/10.1016/j.ijpara.2005.07.014.CrossRefPubMed

15.

Romig T, Kratzer W, Kimmig P, Frosch M, Gaus W, Flegel WA, Gottstein B, Lucius R, Beckh K, Kern P. An epidemiologic survey of human alveolar echinococcosis in southwestern Germany. Römerstein Study Group. Am J Trop Med Hyg. 1999;61:566–73. https://doi.org/10.4269/ajtmh.1999.61.566.CrossRefPubMed

16.

Stieger C, Hegglin D, Schwarzenbach G, Mathis A, Deplazes P. Spatial and temporal aspects of urban transmission of Echinococcus multilocularis. Parasitology. 2002;124:631–40. https://doi.org/10.1017/s0031182002001749.CrossRefPubMed

17.

Gottstein B, Saucy F, Deplazes P, Reichen J, Demierre G, Busato A, Zuercher C, Pugin P. Is high prevalence of Echinococcus multilocularis in wild and domestic animals associated with disease incidence in humans? Emerg Infect Dis. 2001;7:408–12. https://doi.org/10.3201/eid0703.010307.CrossRefPubMedPubMedCentral

18.

Hegglin D, Deplazes P. Control of Echinococcus multilocularis: strategies, feasibility and cost-benefit analyses. Int J Parasitol. 2013;43:327–37. https://doi.org/10.1016/j.ijpara.2012.11.013.CrossRefPubMed

Title: Spatial distribution and incidence trend of human alveolar echinococcosis in southwest Germany: increased incidence and urbanization of the disease?
Authors: Matthias C. Mueller
Michael Marx
Gabriele Peyerl-Hoffmann
Winfried V. Kern
Publication date: 01-12-2020
Publisher: Springer Berlin Heidelberg
Keyword: Echinococcosis
Published in: Infection / Issue 6/2020
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI: https://doi.org/10.1007/s15010-020-01479-4

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2020

Detailed hemodynamics of fulminant myocarditis caused by COVID-19

Myocarditis in admitted patients with dengue fever

Risk for infective endocarditis in bacteremia with Gram positive cocci

Extended-spectrum beta-lactamase (ESBL) producing Enterobacterales in stool surveillance cultures of preterm infants are no risk factor for necrotizing enterocolitis: a retrospective case–control study over 12 years

Bloodstream infection due to Enterobacter ludwigii, correlating with massive aggregation on the surface of a central venous catheter

The epidemiological burden and overall distribution of chronic comorbidities in coronavirus disease-2019 among 202,005 infected patients: evidence from a systematic review and meta-analysis

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage